Cannabinoids and the endocannabinoid system in liver diseases

Cannabinoids and the endocannabinoid system in liver diseases

Cannabinoids are biologically active substances acting via feedback-coupled CB1 and CB2 receptors. Their expression in myofibroblasts and liver endothelial cells is reported to be elevated in chronic liver diseases. The effect of CB1 receptor stimulation is to increase fibrosis and inflammatory acti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anna Parfieniuk-Kowerda, Diana Martonik, Aleksandra Andrzejuk, Aleksander Tarasik, Robert Flisiak
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-12-01
Series:	Clinical & Experimental Hepatology
Subjects:	liver diseases cannabinoids cb1 cb2 endocannabinoids
Online Access:	https://www.termedia.pl/Cannabinoids-and-the-endocannabinoid-system-in-liver-diseases,80,55209,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior
by: Elena Martin-Garcia, et al.
Published: (2025-02-01)

The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice
by: Tomasz Charytoniuk, et al.
Published: (2025-02-01)

Recent trends in studying of alcohol-induced liver disease
by: I. I. Komkova, et al.
Published: (2011-12-01)

Synthetic CB1 Cannabinoids Promote Tunneling Nanotube Communication, Cellular Migration, and Epithelial–Mesenchymal Transition in Pancreatic PANC-1 and Colorectal SW-620 Cancer Cell Lines
by: David A. Bunsick, et al.
Published: (2025-01-01)

Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection
by: Michaela Dvorakova, et al.
Published: (2025-02-01)

Fault current handling in large-scale MMC-HVDC systems: an improved approach with DC circuit breaker and fault current limiter
by: Rashid Hussain Chandio, et al.
Published: (2025-01-01)

Potentially traumatic childbirth experience, childbirth-related post-traumatic stress disorder symptoms, and the parent-infant relationship in non-birthing parents
by: Rebecca Hunter, et al.
Published: (2025-02-01)

The effect of a single administration of streptozotocin on hippocampus metabolites in NODSCID mice
by: D. A. Tur, et al.
Published: (2018-08-01)

Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use – a review
by: Helena M. Teixeira, et al.
Published: (2025-01-01)

Activation of cannabinoid type 2 (CB2) receptors promotes the maintenance of redox homeostasis and protects against oxidative distress in the Neotropical freshwater fish matrinxã Brycon amazonicus (Characiformes: Bryconidae)
by: Suzana Luisa Alves Fernandes, et al.
Published: (2024-11-01)

EXPERIENCE IN USE OF RECUPERATIVE BURNERS DEVICES IN FURNACES OF PERIODIC ACTION FOR HEAT TREATMENT OF BLANKS IN SPC-2 OJSC «BSW – MANAGEMENT COMPANY OF HOLDING «BMC»
by: D. S. Jadchenko
Published: (2018-01-01)

Unveiling the toxicity of JWH-018 and JWH-019: Insights from behavioral and molecular studies in vivo and vitro
by: Fenghua Zhou, et al.
Published: (2025-01-01)

Involuntary intoxication caused by vaping the synthetic cannabinoid ADB-BUTINACA: A case report
by: Elise M.A. Slob, et al.
Published: (2025-06-01)

Neuroprotective Actions of Cannabinoids in the Bovine Isolated Retina: Role of Hydrogen Sulfide
by: Leah Bush, et al.
Published: (2025-01-01)

Synaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease
by: Judy Cheng, et al.
Published: (2025-02-01)

Synergistic action between a synthetic cannabinoid compound and tramadol in neuropathic pain rats
by: Quiñonez-Bastidas Geovanna Nallely, et al.
Published: (2022-12-01)

Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression
by: Uri Bright, et al.
Published: (2025-01-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions
by: Holger Neb, et al.
Published: (2025-01-01)

Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells
by: Na Tian, et al.
Published: (2025-01-01)

Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
by: Alana C. Costa, et al.
Published: (2025-06-01)

Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
by: C. T. M. I. Issa, et al.
Published: (2025-01-01)

Regulation of noradrenaline synthesis, uptake, and degradation in the left ventricle by fatty acid amide hydrolase (FAAH) inhibitor URB597 in the chronic unpredictable stress model of depression
by: Ferizović Harisa, et al.
Published: (2024-01-01)

The Role of Sulfatides in Liver Health and Disease
by: Lin Chen, et al.
Published: (2025-01-01)

Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico
by: Waqas Safir, et al.
Published: (2025-02-01)

Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
by: Mingyu Wu, et al.
Published: (2025-02-01)

Evaluación de la solución nutritiva Steiner aplicada al cultivo de cáñamo medicinal (Cannabis sativa L.) var. Cherry Oregon, bajo invernadero
by: Michelle Arcos, et al.
Published: (2025-01-01)

Brief exposure to (-) THC affects zebrafish embryonic locomotion with effects that persist into the next generation
by: Md Ruhul Amin, et al.
Published: (2025-01-01)

Estimation of Apolipoprotein A1, Haptoglobin and Alpha 2macroglobulin with some Biochemical Metabolic Markers in Nonalcoholic Fatty Liver Disease Iraqi Patients
by: hiba abid Al-hussein hassan, et al.
Published: (2021-03-01)

Treatment of biliary cysts of the liver and polycystic liver disease: a surgical view
by: M. P. Kochieva, et al.
Published: (2010-02-01)

Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study
by: Ying Di, et al.
Published: (2024-08-01)

Assessment of hypoxia status in a rat chronic liver disease model using IVIM and T1 mapping
by: Wenlu Dong, et al.
Published: (2025-01-01)

Identification of biomarkers for the diagnosis of type 2 diabetes mellitus with metabolic associated fatty liver disease by bioinformatics analysis and experimental validation
by: Guiling Wu, et al.
Published: (2025-01-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory
by: Cilla Zhou, et al.
Published: (2025-02-01)

Cannabigerol and cannabichromene in Cannabis sativa L.
by: Zagožen Marjeta, et al.
Published: (2021-09-01)

Value of EEG in the differentiation of glial tumor and encephalitis: a case report and review of literature
by: M. Jokubaitis, et al.
Published: (2020-12-01)

Principles of effective out-patient diagnostics of diffuse liver diseases
by: Komova A. G., et al.
Published: (2014-11-01)

Transcriptome analysis of liver injury of fatty liver disease induced by ALDH2 deficiency
by: Ziying Xu, et al.
Published: (2025-01-01)

Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways
by: Chengan Xu, et al.
Published: (2025-01-01)